Diabetic Foot Ulcer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global market for diabetic foot ulcer therapeutics is expected to see significant growth, with substantial opportunities for expansion. There is an expected increase in opportunity from 2023 to 2024 and a substantial incremental opportunity between 2024 and 2031. According to Fairfield Market Research, the global diabetic foot ulcer therapeutics market is projected to experience substantial growth during the forecast period, reflecting a remarkable compound annual growth rate (CAGR).

Rising Diabetes Prevalence Boosts Market Prospects

The increasing prevalence of diabetes and the corresponding rise in diabetic foot ulcers are expected to have a positive impact on the global diabetic foot ulcer therapeutics market in the coming years. Additionally, a continued focus on preventing surgeries and amputations is set to drive growth in the diabetic foot ulcer therapeutics market. Diabetes mellitus is a major global public health concern, posing an elevated risk of diabetic foot ulcer development.

Consequently, numerous clinical trials are currently underway, with various organizations actively engaged in extensive research programs aimed at developing innovative therapies for diabetic foot ulcer treatment. Individuals with a heightened diabetes risk are experiencing alarming hospitalization rates due to diabetic foot ulcer infections, leading to an increase in amputations. The rising incidence of diabetes and associated risk factors is expected to propel revenue growth in the global diabetic foot ulcer therapeutics market during the assessment period.

Innovative Products Drive Market Competitiveness

Key players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded product lines to maintain their global market share. In recent decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have focused on introducing breakthrough advanced wound dressings designed for diabetic foot ulcer management.

These advanced dressings offer benefits such as prolonged moisture balance, extended oxygen permeability, antimicrobial activity, growth factor stimulation, and the promotion of autolytic debridement, facilitating the re-epithelialization process. This development is fostering robust growth in the global diabetic foot ulcer therapeutics market.

Neuro-Ischemic Ulcers Take Center Stage

Within the ulcer type segment, Neuro-Ischemic ulcers are expected to be the dominant category, showing significant growth over the forecast period. Their valuation is anticipated to surpass a substantial figure by the end of 2031. Ischemic ulcers, which represented over 5% of revenue share in the global diabetic foot ulcer therapeutics market by the conclusion of 2023, are projected to increase their market share by more than 40 basis points by 2031 compared to 2023.

Revenue from the Ischemic ulcers segment is forecasted to experience strong growth between 2024 and 2031, while surpassing a significant valuation by 2031. In contrast, the Neuro-Ischemic ulcers segment, which held a substantial market value share by the end of 2023, is expected to gain more than 500 basis points in market share by 2031 compared to 2023.

Market Segmentation

By Product Type

Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices
Growth Factors

By Ulcer Type

Neuropathic Ulcers
Ischemic Ulcers
Neuro-Ischemic Ulcers

By End User

Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers

By Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

1. Executive Summary

1.1. Global Diabetic Foot Ulcer Therapeutics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

3.1. Global Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Advance Wound Dressings
  - 3.1.1.2. Skin Substitutes
  - 3.1.1.3. Negative Pressure Wound Therapy Devices
  - 3.1.1.4. Growth Factors
3.2. Global Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Neuropathic Ulcers
  - 3.2.1.2. Ischemic Ulcers
  - 3.2.1.3. Neuro-Ischemic Ulcers
3.3. Global Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospitals
  - 3.3.1.2. Specialty Clinics
  - 3.3.1.3. Long-Term Care Centers
  - 3.3.1.4. Ambulatory Surgical Centers
3.4. Global Diabetic Foot Ulcer Therapeutics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

4.1. North America Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Advance Wound Dressings
  - 4.1.1.2. Skin Substitutes
  - 4.1.1.3. Negative Pressure Wound Therapy Devices
  - 4.1.1.4. Growth Factors
4.2. North America Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Neuropathic Ulcers
  - 4.2.1.2. Ischemic Ulcers
  - 4.2.1.3. Neuro-Ischemic Ulcers
4.3. North America Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Specialty Clinics
  - 4.3.1.3. Long-Term Care Centers
  - 4.3.1.4. Ambulatory Surgical Centers
4.4. North America Diabetic Foot Ulcer Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

5.1. Europe Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Advance Wound Dressings
  - 5.1.1.2. Skin Substitutes
  - 5.1.1.3. Negative Pressure Wound Therapy Devices
  - 5.1.1.4. Growth Factors
5.2. Europe Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Neuropathic Ulcers
  - 5.2.1.2. Ischemic Ulcers
  - 5.2.1.3. Neuro-Ischemic Ulcers
5.3. Europe Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Specialty Clinics
  - 5.3.1.3. Long-Term Care Centers
  - 5.3.1.4. Ambulatory Surgical Centers
5.4. Europe Diabetic Foot Ulcer Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

6.1. Asia Pacific Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Advance Wound Dressings
  - 6.1.1.2. Skin Substitutes
  - 6.1.1.3. Negative Pressure Wound Therapy Devices
  - 6.1.1.4. Growth Factors
6.2. Asia Pacific Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Neuropathic Ulcers
  - 6.2.1.2. Ischemic Ulcers
  - 6.2.1.3. Neuro-Ischemic Ulcers
6.3. Asia Pacific Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Specialty Clinics
  - 6.3.1.3. Long-Term Care Centers
  - 6.3.1.4. Ambulatory Surgical Centers
6.4. Asia Pacific Diabetic Foot Ulcer Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

7.1. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Advance Wound Dressings
  - 7.1.1.2. Skin Substitutes
  - 7.1.1.3. Negative Pressure Wound Therapy Devices
  - 7.1.1.4. Growth Factors
7.2. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Neuropathic Ulcers
  - 7.2.1.2. Ischemic Ulcers
  - 7.2.1.3. Neuro-Ischemic Ulcers
7.3. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Specialty Clinics
  - 7.3.1.3. Long-Term Care Centers
  - 7.3.1.4. Ambulatory Surgical Centers
7.4. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook, 2018 - 2031

8.1. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Advance Wound Dressings
  - 8.1.1.2. Skin Substitutes
  - 8.1.1.3. Negative Pressure Wound Therapy Devices
  - 8.1.1.4. Growth Factors
8.2. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook, by Ulcer Type, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Neuropathic Ulcers
  - 8.2.1.2. Ischemic Ulcers
  - 8.2.1.3. Neuro-Ischemic Ulcers
8.3. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Specialty Clinics
  - 8.3.1.3. Long-Term Care Centers
  - 8.3.1.4. Ambulatory Surgical Centers
8.4. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Diabetic Foot Ulcer Therapeutics Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Diabetic Foot Ulcer Therapeutics Market by Ulcer Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Diabetic Foot Ulcer Therapeutics Market End User, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. B. Braun Melsungen AG
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Smith & Nephew, Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Organogenesis, Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Derma Sciences Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Sigvaris Inc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. 3M
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Acelity L.P. Inc.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Innocoll Holdings plc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Osiris
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Type Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations